The realm of Assisted Reproductive Technologies (ART) is characterized by ceaseless innovation, and American fertility clinics are in the vanguard of these advancements. As we look to the future of fertility treatments in the US, it's clear that emerging technologies and evolving social trends are set to redefine the landscape.

One of the significant predictions for the future of ART revolves around the increasing precision of genetic screening. Preimplantation Genetic Testing (PGT) is a procedure used to screen embryos for genetic diseases before implantation during In Vitro Fertilization (IVF). However, scientific leaps mean that soon, this could evolve beyond identifying genetic diseases. The potential to edit out genetic diseases or select specific traits through tools like CRISPR-Cas9 is tantalizing as much as it is ethically complex.

Such advancements could lead to a highly controversial Gattaca-like scenario, where prospective parents can select for traits like eye color, height, or even intelligence. While the ethical implications of this 'designer babies' phenomenon cannot be ignored, it's crucial to remember that the primary aim of PGT and similar technologies is to reduce the incidence of severe genetic diseases.

Simultaneously, we are witnessing the democratization of fertility treatments. Traditionally, ART has been associated with high costs, positioning it as a preserve of the affluent. However, there is a growing trend towards making fertility treatments more accessible and affordable. This is being accomplished through innovative financing models, legislative changes mandating insurance coverage, and the development of low-cost IVF alternatives.

Innovations like INVOcell - a device that allows fertilization and early embryo development to occur in the woman's body rather than a lab - could dramatically cut costs. Additionally, fertility clinics are increasingly offering 'shared risk' programs, wherein patients pay a flat fee for multiple treatment cycles and receive a refund if they don't result in a live birth. These changes are driven by economic forces and societal shifts towards greater inclusivity and equitable healthcare.

Furthermore, the evolution of fertility preservation is another trend to watch. The technique of egg and sperm freezing for future use is becoming increasingly popular, driven by social changes such as later parenthood and the acknowledgment of diverse family structures. The refinement of vitrification techniques has significantly improved the success rates of egg freezing, making this a viable option for women who wish to delay motherhood.

Moreover, the legal landscape pertaining to fertility treatments is set to change. Currently, US law in this area is a patchwork, with substantial variations across states. The lack of federal oversight has led to some questionable practices. However, in light of the evolving technology and increasingly mainstream status of ART, it's plausible to expect more comprehensive and stringent regulations in the future.

Amidst these trends, the role of Artificial Intelligence (AI) cannot be overlooked. AI is making its mark in fertility clinics by improving the odds of successful implantation during IVF through advanced embryo selection. AI algorithms can analyze thousands of images of embryos and identify patterns that correspond to successful or failed implantations, providing a more objective selection process than the human eye.

Looking ahead, the integration of these technologies and trends promises a future where fertility treatments are more efficient, precise, and inclusive. However, it's important to remember that while technology can facilitate, it cannot replace the role of empathetic, patient-centered care in ART. The fertility clinic of the future will need to balance high-tech advancements with an understanding and support of the emotional journey patients undergo.

In conclusion, as we gaze into the crystal ball of the future of US fertility clinics, it reflects a landscape shaped by genetic precision, AI interventions, affordability, and inclusivity. However, this future will also require careful navigation of ethical quandaries and regulatory challenges. The potential is immense, but so is the responsibility.